Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Anticancer Research
|
January 30, 2003
p63 expression profile in normal and malignant prostate epithelial cells
Leland D Davis, Wei Zhang, Axel Merseburger, et al.
World Journal of Urology
|
March 13, 2012
Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?
Tilman Todenhöfer, Jörg Hennenlotter, Ursula Kühs, et al.
Advances in Therapy
|
March 8, 2017
Expert System for Bone Scan Interpretation Improves Progression Assessment in Bone Metastatic Prostate Cancer
Fabian Haupt, Georg Berding, Ali Namazian, et al.
BJU International
|
January 12, 2013
Segmental dosimetry, toxicity and long-term outcome in patients with prostate cancer treated with permanent seed implants
Andreas Meyer, Julia Wassermann, Antje Warszawski-Baumann, et al.
Urologie (Heidelberg, Germany)
|
April 13, 2026
[Update of S3 guideline on metastatic prostate cancer-guideline recommendations and expert consensus]
Marc-Oliver Grimm, Christian Gratzke, Boris Hadaschik, et al.
World Journal of Urology
|
January 8, 2024
The landscape of penile cancer research in Germany and Austria: a survey among professors in academic centers holding chair positions and results of a literature search
Semih Sarcan, Ingmar Wolff, Lukas Lusuardi, et al.
Journal for Immunotherapy of Cancer
|
January 10, 2023
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Aristotelis Bamias, Axel Merseburger, Yohann Loriot, et al.
World Journal of Urology
|
October 5, 2011
XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence
Stefan Aufderklamm, Jörg Hennenlotter, Tilman Todenhoefer, et al.
European Urology Focus
|
May 16, 2025
Prostate-specific Antigen Response as a Prognostic Factor for Overall Survival in Patients with Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Systematic Review and Meta-analysis
Marcin Miszczyk, Tamás Fazekas, Paweł Rajwa, et al.
Oncotarget
|
December 16, 2016
MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling
Anne Offermann, Ignacija Vlasic, Isabella Syring, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Anticancer Research
|
January 30, 2003
p63 expression profile in normal and malignant prostate epithelial cells
Leland D Davis, Wei Zhang, Axel Merseburger, et al.
World Journal of Urology
|
March 13, 2012
Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?
Tilman Todenhöfer, Jörg Hennenlotter, Ursula Kühs, et al.
Advances in Therapy
|
March 8, 2017
Expert System for Bone Scan Interpretation Improves Progression Assessment in Bone Metastatic Prostate Cancer
Fabian Haupt, Georg Berding, Ali Namazian, et al.
BJU International
|
January 12, 2013
Segmental dosimetry, toxicity and long-term outcome in patients with prostate cancer treated with permanent seed implants
Andreas Meyer, Julia Wassermann, Antje Warszawski-Baumann, et al.
Urologie (Heidelberg, Germany)
|
April 13, 2026
[Update of S3 guideline on metastatic prostate cancer-guideline recommendations and expert consensus]
Marc-Oliver Grimm, Christian Gratzke, Boris Hadaschik, et al.
World Journal of Urology
|
January 8, 2024
The landscape of penile cancer research in Germany and Austria: a survey among professors in academic centers holding chair positions and results of a literature search
Semih Sarcan, Ingmar Wolff, Lukas Lusuardi, et al.
Journal for Immunotherapy of Cancer
|
January 10, 2023
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Aristotelis Bamias, Axel Merseburger, Yohann Loriot, et al.
World Journal of Urology
|
October 5, 2011
XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence
Stefan Aufderklamm, Jörg Hennenlotter, Tilman Todenhoefer, et al.
European Urology Focus
|
May 16, 2025
Prostate-specific Antigen Response as a Prognostic Factor for Overall Survival in Patients with Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Systematic Review and Meta-analysis
Marcin Miszczyk, Tamás Fazekas, Paweł Rajwa, et al.
Oncotarget
|
December 16, 2016
MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling
Anne Offermann, Ignacija Vlasic, Isabella Syring, et al.
Page
of 4